BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 13, 2014
View Archived Issues
Lung adenocarcinoma subtype correlates with KRAS, EGFR and ERBB2 gene mutations
Read More
Plexcera Therapeutics gives details on development of recombinant human acid ceramidase
Read More
Stem cells from subjects with Alzheimer's disease mutation APP V717I analyzed
Read More
Tocagen doses first patient in trial of TOCA-511 and TOCA-FC
Read More
First patient enrolled in study of triheptanoin in GLUT-1 deficiency syndrome
Read More
Roche synthesizes dual FABP inhibitors
Read More
Ventana Medical Systems and Bayer extend companion diagnostics collaboration
Read More
MTL-005 demonstrates radiosensitizing effects in mouse models of squamous cell carcinoma
Read More
Grespo presents lead compound for mild cognitive impairment
Read More
Safety monitoring board issues positive assessment of phase IIb TNF-Kinoid trial
Read More
Fate Therapeutics begins phase II trial of ProHema for hematologic malignancies
Read More
Upsher-Smith Laboratories receives FDA approval for Qudexy XR
Read More
Viamet reports interim data from phase II study of VT-1161
Read More
Pharmascience divulges novel BTK inhibitors
Read More
FDA approves Mallinckrodt's Xartemis XR
Read More
Novel H3R ligands disclosed by Suven Life Sciences
Read More
N30 Pharmaceuticals begins phase I trial of N-91115 for cystic fibrosis
Read More
Suzhou Zelgen Biosciences discloses novel coagulation factor Xa inhibitors
Read More
FDA places imetelstat on clinical hold
Read More
Lubiprostone not approved in the U.K. for opioid-induced constipation
Read More
World Kidney Day: Early diagnosis and more accessible solutions for chronic kidney disease
Read More
New U.K. phase II study investigates olaparib for NSCLC
Read More
Genexine plans Korean study of GX-051 for advanced head and neck cancer
Read More
New study investigates riociguat in PAH patients with insufficient response to PDE5 inhibitors
Read More
Taigexyn approved in Taiwan for CAP
Read More